InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Pamukcu Rifat. Officer active across 1 company, notably Aprea Therapeutics, Inc.. Cumulatively, 5 reports have been logged. Activity tracked since 28 July 2022. The latest transaction was filed on 5 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Pamukcu Rifat is a declarant linked to Aprea Therapeutics, Inc., where he is a Director. The record shows 4 filings in total, and across the 4 most recent filings we hold, the modal transaction nature is Attribution, with buy and sell amounts of EUR 0 and a date range from 2022-08-01 to 2026-06-17.